DR Reddys Laboratories Limited — Valsartan Exporter Profile
Indian Pharmaceutical Exporter · #14 for Valsartan · $1.4M export value · DGFT Verified
DR Reddys Laboratories Limited is the #14 Indian exporter of Valsartan with $1.4M in export value and 30 verified shipments. DR Reddys Laboratories Limited holds a 0.7% market share in Valsartan exports across 3 countries. The company exports 37 pharmaceutical products worth $62.4M across 17 therapeutic categories.
DR Reddys Laboratories Limited — Valsartan Export Profile: Buyers & Destinations
Where Does DR Reddys Laboratories Limited Export Valsartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $593.3K | 13 | 98.0% |
| MALTA | $12.3K | 11 | 2.0% |
| BRAZIL | $24 | 6 | 0.0% |
DR Reddys Laboratories Limited exports Valsartan to 3 countries. The largest destination is UNITED STATES accounting for 98.0% of DR Reddys Laboratories Limited's Valsartan shipments, followed by MALTA (2.0%) and BRAZIL (0.0%). These destinations reflect DR Reddys Laboratories Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Valsartan from DR Reddys Laboratories Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DR REDDY SLABORATORIES INC | UNITED STATES | $355.0K | 8 |
| DR REDDYS LABORATORIES INC | UNITED STATES | $238.4K | 5 |
| EXPRESS TRAILER LIMITED | MALTA | $12.3K | 11 |
| DR REDDY S FARMACEUTICA DO BRASIL | BRAZIL | $24 | 2 |
| DR REDDY S FARMACEUTICA DO BRASIL L TDA | BRAZIL | $0 | 4 |
DR Reddys Laboratories Limited supplies Valsartan to 5 buyers globally. The largest buyer is DR REDDY SLABORATORIES INC (UNITED STATES), followed by DR REDDYS LABORATORIES INC (UNITED STATES) and EXPRESS TRAILER LIMITED (MALTA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Valsartan Export Value and How Much Does DR Reddys Laboratories Limited Contribute?
India exported $113.6M worth of Valsartan through 6,098 shipments from 259 suppliers to 119 countries, serving 663 buyers globally. DR Reddys Laboratories Limited contributes $1.4M to this total, accounting for 0.7% of India's Valsartan exports. DR Reddys Laboratories Limited ships Valsartan to 3 countries through 5 buyers.
What Is the Average Shipment Value for DR Reddys Laboratories Limited's Valsartan Exports?
DR Reddys Laboratories Limited's average Valsartan shipment value is $45.7K per consignment, based on 30 shipments totaling $1.4M. The largest destination is UNITED STATES (98.0% of DR Reddys Laboratories Limited's Valsartan exports).
How Does DR Reddys Laboratories Limited Compare to Other Indian Valsartan Exporters?
DR Reddys Laboratories Limited ranks #14 among 259 Indian Valsartan exporters with a 0.7% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($28.9M), MACLEODS PHARMACEUTICALS LTD ($27.9M), ALEMBIC PHARMACEUTICALS LIMITED ($10.5M). DR Reddys Laboratories Limited processed 30 shipments to 3 destination countries.
What Valsartan Formulations Does DR Reddys Laboratories Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| VALSARTAN TABLETS USP 320MG90'S17542X 90S PACKS= 1578780 NOS | $100.0K | 2 |
| VALSARTAN TABLETS USP 160MG 90S 23770 X90S PACKS=2139300 NOS | $100.0K | 2 |
| VALSARTAN TABLETS USP 320MG 90S 11712 X90S PACKS=1054080 NOS | $50.0K | 1 |
| VALSARTAN TABLETS USP 80MG 90 S 27106 X90 S PACKS = 2439540 NOS | $50.0K | 1 |
| 300019504 VALSARTAN TABLETS USP 160MG 90S 11976 SU X 90=10,77,840 NOS | $50.0K | 1 |
| VALSARTAN TABLETS USP 320MG 90 S 17270X 90 S PACKS = 1554300 NOS | $50.0K | 1 |
| VALSARTAN TABLETS USP 160MG 90S 47286 X90S PACKS=4255740 NOS | $50.0K | 1 |
| 300019505 VALSARTAN TABLETS USP 320MG 90S 23646 SU X 90 =2128140 NOS | $50.0K | 1 |
| VALSARTAN TABLETS USP 80MG 90S 13488 X90S PACKS=1213920 NOS | $38.4K | 1 |
| VALSARTAN TABLETS USP 80MG 90S 13320 X90S PACKS=1198800 NOS | $38.0K | 1 |
DR Reddys Laboratories Limited exports 27 distinct Valsartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VALSARTAN TABLETS USP 320MG90'S17542X 90S PACKS= 1578780 NOS with 2 shipments worth $100.0K.
Regulatory Requirements: Exporting Valsartan to Key Markets
What DR Reddys Laboratories Limited must comply with to export Valsartan to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does DR Reddys Laboratories Limited Compare to Nearest Valsartan Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | TORRENT PHARMACEUTICALS LTD | $1.5M | 65 | 4 | $23.3K |
| 13 | ZYDUS LIFESCIENCES LIMITED | $1.4M | 64 | 7 | $21.7K |
| 14 | DR REDDYS LABORATORIES LIMITED ★ | $1.4M | 30 | 3 | $45.7K |
| 15 | DR REDDY S LABORATORIES LIMITED | $900.0K | 18 | 1 | $50.0K |
DR Reddys Laboratories Limited ranks #14 among 259 Indian Valsartan exporters. Average shipment value of $45.7K compared to the market average of $438.5K. The closest competitors by value are TORRENT PHARMACEUTICALS LTD and ZYDUS LIFESCIENCES LIMITED.
Which Indian Ports Ship Valsartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 946 | 15.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 707 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 627 | 10.3% |
| DELHI AIR | 516 | 8.5% |
| NHAVA SHEVA SEA (INNSA1) | 445 | 7.3% |
| JNPT/ NHAVA SHEVA SEA | 323 | 5.3% |
| JNPT | 213 | 3.5% |
| MUNDRA SEA | 176 | 2.9% |
What Other Cardiovascular Products Does DR Reddys Laboratories Limited Export?
DR Reddys Laboratories Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on DR Reddys Laboratories Limited's Valsartan Exports
The global pharmaceutical export landscape has been significantly influenced by recent geopolitical events. The 2026 Strait of Hormuz crisis, initiated by military conflicts involving the United States, Israel, and Iran, led to the effective halt of shipping traffic through this critical maritime route, disrupting approximately 20% of the world's daily oil supply and causing a surge in global energy prices. (en.wikipedia.org) This disruption has had a cascading effect on shipping costs and insurance premiums, directly impacting Indian pharmaceutical exporters like Dr. Reddy's, which rely on these routes for timely delivery of products to key markets.
Simultaneously, the 2025–26 United States–India diplomatic and trade crisis, marked by the imposition of a 50% tariff on Indian exports by the U.S., has posed additional challenges. These tariffs have increased the cost of Indian pharmaceutical products in the U.S. market, potentially affecting the competitiveness of companies like Dr. Reddy's. (en.wikipedia.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. Dr. Reddy's has been proactive in adhering to these regulations, ensuring that its products meet the stringent safety and traceability standards mandated by the EU, thereby maintaining its market access and reputation.
DR Reddys Laboratories Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Dr. Reddy's has demonstrated a commitment to quality by securing approvals from major regulatory bodies, including the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Medicines Agency (EMA). The company's recent Biologics License Application (BLA) submission for a proposed interchangeable biosimilar to Orencia® (abatacept) underscores its adherence to rigorous regulatory processes. (stockwatch.com)
However, the company has faced regulatory challenges, such as the tax audit decision from the Russian Federal Tax Service in January 2026, which reclassified certain marketing services as taxable, resulting in a penalty. (stocktitan.net) Such incidents highlight the complexities of operating in diverse regulatory environments and the importance of robust compliance frameworks.
About DR Reddys Laboratories Limited
DR Reddys Laboratories Limited exports 37 products worth $62.4M. Beyond Valsartan, top products include Omeprazole, Metoprolol, Diclofenac, Clopidogrel, Fexofenadine. View the complete DR Reddys Laboratories Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Valsartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Valsartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: DR Reddys Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 30 individual customs records matching DR Reddys Laboratories Limited exporting Valsartan, covering 27 formulations to 3 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 663+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Valsartan Export Data from DR Reddys Laboratories Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for DR Reddys Laboratories Limited's Valsartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
DR Reddys Laboratories Limited
Full Company Profile →
37 products · $62.4M total trade · 17 categories
Valsartan Stats
Company Overview
Top Products by DR Reddys Laboratories Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for DR Reddys Laboratories Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Valsartan. For current shipment-level data, contact TransData Nexus.